KPIs & Operating Metrics(New)
Balance Sheet
Accumulated DepreciationAccumulated ExpensesAssetsBuildingsCash & EquivalentsCommon EquityDividends payablesGoodwillGoodwill & IntangiblesIntangiblesLand & ImprovementsLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsReal Estate - GrossReal Estate - NetReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Global Medical REIT (GMRE) Total Debt (2016 - 2025)

Historic Total Debt for Global Medical REIT (GMRE) over the last 14 years, with Q3 2025 value amounting to $708.5 million.

  • Global Medical REIT's Total Debt rose 1531.62% to $708.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $708.5 million, marking a year-over-year increase of 1531.62%. This contributed to the annual value of $631.7 million for FY2024, which is 792.69% up from last year.
  • Latest data reveals that Global Medical REIT reported Total Debt of $708.5 million as of Q3 2025, which was up 1531.62% from $698.8 million recorded in Q2 2025.
  • Global Medical REIT's Total Debt's 5-year high stood at $708.5 million during Q3 2025, with a 5-year trough of $420.2 million in Q1 2021.
  • Its 5-year average for Total Debt is $586.0 million, with a median of $599.0 million in 2024.
  • As far as peak fluctuations go, Global Medical REIT's Total Debt surged by 3637.92% in 2022, and later plummeted by 1167.35% in 2023.
  • Over the past 5 years, Global Medical REIT's Total Debt (Quarter) stood at $514.6 million in 2021, then rose by 23.69% to $636.4 million in 2022, then decreased by 8.03% to $585.3 million in 2023, then grew by 7.93% to $631.7 million in 2024, then rose by 12.15% to $708.5 million in 2025.
  • Its last three reported values are $708.5 million in Q3 2025, $698.8 million for Q2 2025, and $662.8 million during Q1 2025.